1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Physical Exam
1.2.3 Laboratory Tests
1.2.4 Imaging Tests
1.2.5 Gleason Score
1.2.6 TNM Score
1.2.7 Genetic Tests
1.2.8 Digital Rectal Exam
1.2.9 Biopsy
1.3 Market by Application
1.3.1 Global Prostate Cancer Screening Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Labs
1.3.5 Cancer Institutes
1.3.6 Diagnostic Centers
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Screening Market Perspective (2018-2030)
2.2 Prostate Cancer Screening Growth Trends by Region
2.2.1 Prostate Cancer Screening Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Prostate Cancer Screening Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Screening Forecasted Market Size by Region (2023-2030)
2.3 Prostate Cancer Screening Market Dynamics
2.3.1 Prostate Cancer Screening Industry Trends
2.3.2 Prostate Cancer Screening Market Drivers
2.3.3 Prostate Cancer Screening Market Challenges
2.3.4 Prostate Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Screening Players by Revenue
3.1.1 Global Top Prostate Cancer Screening Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Screening Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Screening Revenue
3.4 Global Prostate Cancer Screening Market Concentration Ratio
3.4.1 Global Prostate Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Screening Revenue in 2022
3.5 Prostate Cancer Screening Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Screening Product Solution and Service
3.7 Date of Enter into Prostate Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Screening Breakdown Data by Type
4.1 Global Prostate Cancer Screening Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Screening Forecasted Market Size by Type (2023-2030)
5 Prostate Cancer Screening Breakdown Data by Application
5.1 Global Prostate Cancer Screening Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Screening Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Prostate Cancer Screening Market Size (2018-2030)
6.2 North America Prostate Cancer Screening Market Size by Country (2018-2023)
6.3 North America Prostate Cancer Screening Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Prostate Cancer Screening Market Size (2018-2030)
7.2 Europe Prostate Cancer Screening Market Size by Country (2018-2023)
7.3 Europe Prostate Cancer Screening Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Screening Market Size (2018-2030)
8.2 Asia-Pacific Prostate Cancer Screening Market Size by Country (2018-2023)
8.3 Asia-Pacific Prostate Cancer Screening Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Prostate Cancer Screening Market Size (2018-2030)
9.2 Latin America Prostate Cancer Screening Market Size by Country (2018-2023)
9.3 Latin America Prostate Cancer Screening Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Screening Market Size (2018-2030)
10.2 Middle East & Africa Prostate Cancer Screening Market Size by Country (2018-2023)
10.3 Middle East & Africa Prostate Cancer Screening Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Prostate Cancer Screening Introduction
11.1.4 Abbott Laboratories Revenue in Prostate Cancer Screening Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Almac
11.2.1 Almac Company Detail
11.2.2 Almac Business Overview
11.2.3 Almac Prostate Cancer Screening Introduction
11.2.4 Almac Revenue in Prostate Cancer Screening Business (2018-2023)
11.2.5 Almac Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Prostate Cancer Screening Introduction
11.3.4 Bayer Revenue in Prostate Cancer Screening Business (2018-2023)
11.3.5 Bayer Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Screening Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Screening Business (2018-2023)
11.4.5 Beckman Coulter Recent Development
11.5 Biom?Rieux
11.5.1 Biom?Rieux Company Detail
11.5.2 Biom?Rieux Business Overview
11.5.3 Biom?Rieux Prostate Cancer Screening Introduction
11.5.4 Biom?Rieux Revenue in Prostate Cancer Screening Business (2018-2023)
11.5.5 Biom?Rieux Recent Development
11.6 Genomic Health
11.6.1 Genomic Health Company Detail
11.6.2 Genomic Health Business Overview
11.6.3 Genomic Health Prostate Cancer Screening Introduction
11.6.4 Genomic Health Revenue in Prostate Cancer Screening Business (2018-2023)
11.6.5 Genomic Health Recent Development
11.7 Mayo Clinic
11.7.1 Mayo Clinic Company Detail
11.7.2 Mayo Clinic Business Overview
11.7.3 Mayo Clinic Prostate Cancer Screening Introduction
11.7.4 Mayo Clinic Revenue in Prostate Cancer Screening Business (2018-2023)
11.7.5 Mayo Clinic Recent Development
11.8 Mdxhealth
11.8.1 Mdxhealth Company Detail
11.8.2 Mdxhealth Business Overview
11.8.3 Mdxhealth Prostate Cancer Screening Introduction
11.8.4 Mdxhealth Revenue in Prostate Cancer Screening Business (2018-2023)
11.8.5 Mdxhealth Recent Development
11.9 Roche Diagnostics
11.9.1 Roche Diagnostics Company Detail
11.9.2 Roche Diagnostics Business Overview
11.9.3 Roche Diagnostics Prostate Cancer Screening Introduction
11.9.4 Roche Diagnostics Revenue in Prostate Cancer Screening Business (2018-2023)
11.9.5 Roche Diagnostics Recent Development
11.10 Rosetta Genomics
11.10.1 Rosetta Genomics Company Detail
11.10.2 Rosetta Genomics Business Overview
11.10.3 Rosetta Genomics Prostate Cancer Screening Introduction
11.10.4 Rosetta Genomics Revenue in Prostate Cancer Screening Business (2018-2023)
11.10.5 Rosetta Genomics Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Detail
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Prostate Cancer Screening Introduction
11.11.4 Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2018-2023)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Hologic
11.12.1 Hologic Company Detail
11.12.2 Hologic Business Overview
11.12.3 Hologic Prostate Cancer Screening Introduction
11.12.4 Hologic Revenue in Prostate Cancer Screening Business (2018-2023)
11.12.5 Hologic Recent Development
11.13 Myriad Genetics
11.13.1 Myriad Genetics Company Detail
11.13.2 Myriad Genetics Business Overview
11.13.3 Myriad Genetics Prostate Cancer Screening Introduction
11.13.4 Myriad Genetics Revenue in Prostate Cancer Screening Business (2018-2023)
11.13.5 Myriad Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
